Nuvation Bio EBITDA 2020-2024 | NUVB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Nuvation Bio ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Nuvation Bio ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$171.5B
Vertex Pharmaceuticals (VRTX)	$121.6B
Gilead Sciences (GILD)	$111.4B
Bristol Myers Squibb (BMY)	$110.2B
Regeneron Pharmaceuticals (REGN)	$93B
CSL (CSLLY)	$90B
GSK (GSK)	$76.4B
Argenex SE (ARGX)	$35.6B
Alnylam Pharmaceuticals (ALNY)	$35.3B
BioNTech SE (BNTX)	$26.5B
Biogen (BIIB)	$25.3B
Illumina (ILMN)	$23.9B
Moderna (MRNA)	$21B
BeiGene (BGNE)	$19.9B
Genmab (GMAB)	$14.9B
Incyte (INCY)	$14.7B
Exact Sciences (EXAS)	$12.9B
BioMarin Pharmaceutical (BMRN)	$12.7B
Vaxcyte (PCVX)	$12B
Bio-Techne Corp (TECH)	$11.9B
Sarepta Therapeutics (SRPT)	$11.8B
Insmed (INSM)	$11.7B
QIAGEN (QGEN)	$9.8B
Exelixis (EXEL)	$9.7B
Bio-Rad Laboratories (BIO.B)	$9.3B
Revolution Medicines (RVMD)	$9.2B
Intra-Cellular Therapies (ITCI)	$9.2B
Roivant Sciences (ROIV)	$8.6B
Viking Therapeutics (VKTX)	$8.1B
Legend Biotech (LEGN)	$8.1B